{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:04:43Z","timestamp":1774343083216,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord Ser Cases"],"DOI":"10.1038\/s41394-024-00642-5","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T05:02:09Z","timestamp":1714021329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6498-7736","authenticated-orcid":false,"given":"Muhamad Faizal","family":"Zainudin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Razali","family":"Hasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Eleanor","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanalactchumy","family":"Chandrabose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"642_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Group TMCW.","year":"2002","unstructured":"Group TMCW. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499\u2013505.","journal-title":"Neurology"},{"key":"642_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653786","volume":"12","author":"GC Rom\u00e1n","year":"2021","unstructured":"Rom\u00e1n GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021;12:653786.","journal-title":"Front Immunol"},{"key":"642_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2040239","volume":"18","author":"SF Maroufi","year":"2022","unstructured":"Maroufi SF, Naderi Behdani F, Rezania F, Tanhapour Khotbehsara S, Mirzaasgari Z. Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature. Hum Vaccin Immunother. 2022;18:2040239.","journal-title":"Hum Vaccin Immunother"},{"key":"642_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577606","volume":"358","author":"C Pagenkopf","year":"2021","unstructured":"Pagenkopf C, S\u00fcdmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol. 2021;358:577606.","journal-title":"J Neuroimmunol"},{"key":"642_CR5","volume":"13","author":"N Tahir","year":"2021","unstructured":"Tahir N, Koorapati G, Prasad S, Jeelani HM, Sherchan R, Shrestha J, et al. SARS-CoV-2 Vaccination-Induced Transverse Myelitis. Cureus. 2021;13:e16624.","journal-title":"Cureus"},{"key":"642_CR6","volume":"2022","author":"PD da Gama","year":"2022","unstructured":"da Gama PD, de Alcantara TG, Smaniotto RR, Petuco PL, et al. Extensive longitudinal transverse myelitis temporally related to the use of AZD1222, AstraZeneca COVID-19 vaccine: cerebrospinal fluid analysis and recent data review. Case Rep Neurol Med. 2022;2022:8999853.","journal-title":"Case Rep Neurol Med"},{"key":"642_CR7","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e52","volume":"37","author":"H Eom","year":"2022","unstructured":"Eom H, Kim SW, Kim M, Kim YE, Kim JH, Shin HY, et al. Case reports of acute transverse myelitis associated With mRNA vaccine for COVID-19. J Korean Med Sci. 2022;37:e52.","journal-title":"J Korean Med Sci"},{"key":"642_CR8","volume":"13","author":"J Alabkal","year":"2021","unstructured":"Alabkal J, Rebchuk AD, Lyndon D, Randhawa N. Incomplete subacute transverse myelitis following vaccination with Pfizer-BioNTech COVID-19 mRNA vaccine: a case report. Cureus. 2021;13:e20460.","journal-title":"Cureus"},{"key":"642_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120102","volume":"434","author":"H Nakano","year":"2022","unstructured":"Nakano H, Yamaguchi K, Kawabata K, Asakawa M, Matsumoto Y. Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature. J Neurol Sci. 2022;434:120102.","journal-title":"J Neurol Sci"},{"key":"642_CR10","doi-asserted-by":"crossref","unstructured":"Fitzsimmons W, Nance CS Sudden onset of myelitis after COVID-19 vaccination: an under-recognized severe rare adverse event. Available at SSRN 2021 3841558.","DOI":"10.2139\/ssrn.3841558"},{"key":"642_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.18071\/isz.74.0273","volume":"74","author":"N Erdem","year":"2021","unstructured":"Erdem N, Demirci S, \u00d6zel T, Mamadova K, Karaali K, \u00c7elik HT, et al. Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogy Sz. 2021;74:273\u20136.","journal-title":"Ideggyogy Sz"},{"key":"642_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99\u2013111.","journal-title":"Lancet"},{"key":"642_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jaut.1999.0346","volume":"14","author":"Y Shoenfeld","year":"2000","unstructured":"Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-\u2018vaccinosis\u2019: a dangerous liaison? J Autoimmun. 2000;14:1\u201310.","journal-title":"J Autoimmun"},{"key":"642_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108665","volume":"224","author":"R Talotta","year":"2021","unstructured":"Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2021;224:108665.","journal-title":"Clin Immunol"},{"key":"642_CR15","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jcpa.2007.04.013","volume":"137","author":"S Goriely","year":"2007","unstructured":"Goriely S, Goldman M. From tolerance to autoimmunity: is there a risk in early life vaccination? J Comp Pathol. 2007;137:S57\u201361.","journal-title":"J Comp Pathol"},{"key":"642_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02427-x","volume":"21","author":"WY Tan","year":"2021","unstructured":"Tan WY, Yusof Khan AHK, Mohd Yaakob MN, Abdul Rashid AM, Loh WC, Baharin J, et al. Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC Neurol. 2021;21:395.","journal-title":"BMC Neurol"},{"key":"642_CR17","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.7861\/clinmed.2021-0470","volume":"21","author":"AA Notghi","year":"2021","unstructured":"Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Lond). 2021;21:e535\u2013e8.","journal-title":"Clin Med (Lond)"},{"key":"642_CR18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/nau.23397","volume":"37","author":"JB Gajewski","year":"2018","unstructured":"Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agr\u00f2 EF, et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37:1152\u201361.","journal-title":"Neurourol Urodyn"},{"key":"642_CR19","unstructured":"Innovation NAfC. Management of the Neurogenic Bladder for Adults with Spinal Cord Injuries2013 [cited 2023 August 13]. Available from: https:\/\/aci.health.nsw.gov.au\/__data\/assets\/pdf_file\/0010\/155179\/ACI-Management-neurogenic-bladder-adults-sci.pdf."}],"container-title":["Spinal Cord Series and Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41394-024-00642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-024-00642-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-024-00642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T05:02:32Z","timestamp":1714021352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41394-024-00642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1038\/s41394-024-00642-5","relation":{},"ISSN":["2058-6124"],"issn-type":[{"value":"2058-6124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"2 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research has been conducted with the ethical approval of the National Medical Research Register Malaysia (NMRR ID-23-00250-GHX). Informed consent was also obtained from the patient for the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30"}}